Day One Biopharmaceuticals Inc (DAWN)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form POSASR - Post-effective Amendment to an automatic shelf registration statement

Form POSASR - Post-effective Amendment to an automatic shelf registration statement

Form 8-K - Current report

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Servier completes the acquisition of Day One Biopharmaceuticals

Servier completes the acquisition of Day One Biopharmaceuticals PR Newswire SURESNES, France, April 23...

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]